ELAC2 and prostate carcinoma: Due to the marked inconsistency in findings of the association of ELAC2 polymorphism and prostate cancer in different geographical locations and ethnicities, establishment of this association in the Cameroonian population can throw more light on this association as well as revealing new insights with regards to the management of the disease in this area.